Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040155 · ClinicalTrials.gov registry record · NA
Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02040155 is a NA study that has completed, run by Duke University. The registered enrollment target is 16 participants.
The verdict
NCT02040155, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is an observational study. The purpose is to determine the feasibility of using a novel nano-scintillator fiber-optic dosimeter (nanoFOD) for the real time dosimetric monitoring of brachytherapy treatment. Women with gynecologic cancers treated with brachytherapy as part of their standard therapeutic regimen will represent the study population.
Interventions
- DEVICE Novel nano-scintillator fiber-optic dosimeter (nanoFOD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02040155
The ClinicalTrials.gov registry entry for NCT02040155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel nano-scintillator fiber-optic dosimeter (nanoFOD) is the first listed.
NCT02040155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02040155 about?
NCT02040155 is a clinical study titled "Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy". This is an observational study. The purpose is to determine the feasibility of using a novel nano-scintillator fiber-optic dosimeter (nanoFOD) for the real time dosimetric monitoring of brachytherapy treatment. Women with gynecologic cancers treated with brachytherapy as part of their standard thera...
What is the current status of trial NCT02040155?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-02. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02040155?
The interventions under investigation include: Novel nano-scintillator fiber-optic dosimeter (nanoFOD) (DEVICE).
Who is sponsoring clinical trial NCT02040155?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.